Browse Cases

• Filed

Civil case currently marked active.

• Filed

Civil case currently marked active.

• Filed

Plaintiffs identified as Milano have filed a civil suit against ALDI in New Jersey federal court under docket 26-cv-01675. A notice of appearance has been filed, placing the case in its earliest active stage. ALDI is a large discount grocery chain; suits against it in federal court commonly involve premises liability

• Filed

Genentech has filed a patent infringement case against Natco Pharma in New Jersey federal court under docket 24-cv-11308, and the case has been reassigned to a new judge. Genentech is a major biopharmaceutical company with an extensive patent portfolio; Natco is an Indian generic drug manufacturer with a U.S. presence

• Filed

A plaintiff named Williams has filed a federal civil suit against BMW of North America in New Jersey under docket 25-cv-16718. The docket entry reflects an administrative flag-setting action, which provides no detail on the underlying claims. Cases against auto manufacturers in New Jersey federal court commonly

• Filed

USA v. Bradberry is a criminal matter filed in 2010 under docket 10-mj-03096, with reentry or drug court proceedings currently active. The age of the docket suggests this is a supervision or compliance matter rather than a new prosecution. Reentry proceedings typically involve a defendant returning from incarceration

• Filed

Azurity Pharmaceuticals filed suit against Lupin in federal court under docket 25-cv-13133, asserting drug patent claims. The case was recently reassigned, which may reflect a judicial conflict, docket management, or consolidation with related Hatch-Waxman litigation. Azurity specializes in specialty and rare-disease

• Filed

Oxford House is seeking additional time to file a response in a federal civil suit pending in New Jersey under docket 21-cv-19260. The case involves Oxford House, a nonprofit that operates sober living homes, and the municipality of North Bergen. Extension requests at this stage typically signal active briefing on a

• Filed

The United States is prosecuting defendant Felder in a case docketed as 19-cr-00343, which remains active in drug court proceedings. The 2019 docket date and continued drug court status indicate Felder has been in a supervised treatment or reentry program for several years. Drug court programs are structured

• Filed

Esperion Therapeutics filed a separate federal patent suit against Sandoz Inc. under docket 24-cv-06387, and that case has also been reassigned. Filing parallel Hatch-Waxman suits against multiple generic manufacturers is standard practice when several companies challenge the same branded drug's patents

• Filed

The United States is prosecuting defendant Mercado in New Jersey federal court under docket 20-cr-00973. A plea agreement hearing has been scheduled, indicating the parties have reached or are close to a negotiated disposition. Plea hearings at this stage typically involve the court conducting a Rule 11 colloquy to

• Filed

Esperion Therapeutics filed suit against Aurobindo Pharma in a patent dispute docketed as 24-cv-06348. The case was recently reassigned to a new judge, which can signal docket management changes or recusal but does not affect the underlying merits. Esperion develops cardiovascular drugs, and patent litigation against

• Filed

The United States is prosecuting defendant Trowell in New Jersey federal court under docket 17-cr-00523. Active reentry and drug court proceedings indicate the case has moved into a supervised compliance or post-conviction phase rather than active trial posture. Cases in reentry or drug court programs typically

• Filed

Plaintiff Mateo filed a stipulation against Resurgent Capital Services in a civil action docketed as 26-cv-02141. The filing suggests the parties may be moving toward a negotiated resolution, though the court and full terms of the stipulation are not yet confirmed in the available record. Resurgent Capital Services is

• Filed

Esperion Therapeutics has filed a patent case against Renata, docket 24-cv-06017, which has been reassigned to a new judge. Esperion develops cardiovascular drugs, and Renata is a pharmaceutical manufacturer, suggesting this is a Hatch-Waxman patent dispute tied to a generic drug application. Case reassignment at this

• Filed

Plaintiff Mincer has filed a federal civil action against Target Corporation, docket 25-cv-14913. The court has set a hearing, placing the case in early active litigation. Suits against Target in federal court commonly involve premises liability, slip-and-fall injuries, employment discrimination, or consumer

• Filed

The United States is prosecuting defendant Melbourne in a federal criminal case, docket 19-cr-00675, which has been pending since 2019. A hearing has been set or reset, indicating the case remains active more than five years after filing. The age of this docket is notable. Cases that persist this long often involve

• Filed

Plaintiff Bishop is suing Intercruises Shoreside Port Services and additional defendants in a federal civil action, docket 26-cv-03634. The case is at an early stage, with only a notice filing on record. Intercruises provides port and shore excursion services to the cruise industry. Bishop's claims likely arise from a

• Filed

The United States is prosecuting defendant Quezada in a federal magistrate-level criminal matter, docket 25-mj-15008. The court has granted a motion to continue speedy trial deadlines, pausing the Speedy Trial Act clock. Magistrate-level cases typically involve initial appearances, detention hearings, or preliminary

• Filed

Plaintiff Connell is suing the Department of State in a federal civil action, docket 24-cv-02030. The case is at a status report stage, suggesting active case management is underway. The Department of State is a federal agency defendant, which typically means this action may involve administrative law claims such as a